Skip to main content
. 2024 Oct 9;41(12):4384–4395. doi: 10.1007/s12325-024-02984-w

Fig. 2.

Fig. 2

Efficacy of biologics on reduced sense of smell assessed using UPSIT (AC) and on HRQoL assessed using SNOT-22 (DF) in phase III clinical trials. Data from aBachert et al. [43]; bGevaert et al. [45]; cHan et al. [46]. HRQoL health-related quality of life, LS least-squares, q2w every 2 weeks, q4w every 4 weeks, SNOT-22 22-item Sino-Nasal Outcome Test, UPSIT University of Pennsylvania Smell Identification Test